These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30647119)

  • 41. Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.
    Chiocco MJ; Kulnane LS; Younkin L; Younkin S; Evin G; Lamb BT
    J Biol Chem; 2004 Dec; 279(50):52535-42. PubMed ID: 15452128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
    Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
    PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.
    Zhao J; O'Connor T; Vassar R
    J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.
    Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
    Mol Med Rep; 2015 Aug; 12(2):3081-8. PubMed ID: 25955795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factor κB (NFκB) signaling.
    Wang R; Chen S; Liu Y; Diao S; Xue Y; You X; Park EA; Liao FF
    J Biol Chem; 2015 Sep; 290(37):22532-42. PubMed ID: 26240147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-site amyloid precursor protein-cleaving enzyme-1 (BACE1)-mediated changes of endogenous amyloid beta in wild-type and transgenic mice in vivo.
    Hirata-Fukae C; Sidahmed EH; Gooskens TP; Aisen PS; Dewachter I; Devijver H; Van Leuven F; Matsuoka Y
    Neurosci Lett; 2008 Apr; 435(3):186-9. PubMed ID: 18343582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
    Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
    J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.
    Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC
    Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice.
    Eketjäll S; Janson J; Jeppsson F; Svanhagen A; Kolmodin K; Gustavsson S; Radesäter AC; Eliason K; Briem S; Appelkvist P; Niva C; Berg AL; Karlström S; Swahn BM; Fälting J
    J Neurosci; 2013 Jun; 33(24):10075-84. PubMed ID: 23761903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aβ1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation.
    Guglielmotto M; Monteleone D; Boido M; Piras A; Giliberto L; Borghi R; Vercelli A; Fornaro M; Tabaton M; Tamagno E
    Aging Cell; 2012 Oct; 11(5):834-44. PubMed ID: 22726800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer's disease.
    Bao J; Qin M; Mahaman YAR; Zhang B; Huang F; Zeng K; Xia Y; Ke D; Wang Q; Liu R; Wang JZ; Ye K; Wang X
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3954-3959. PubMed ID: 29581300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloid.
    Chen Y; Huang X; Zhang YW; Rockenstein E; Bu G; Golde TE; Masliah E; Xu H
    J Neurosci; 2012 Aug; 32(33):11390-5. PubMed ID: 22895721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of huannao yicong recipe extract on the learning and memory and related factors of Abeta generation in the brain of APP transgenic mice].
    Li H; Liu MF; Liu JG; Liu LT; Guan J; Cai LL; Hu J; Wei Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):90-4. PubMed ID: 23596795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.
    Shi Z; Hong Y; Zhang K; Wang J; Zheng L; Zhang Z; Hu Z; Han X; Han Y; Chen T; Yao Q; Cui H; Hong W
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2398-2407. PubMed ID: 28502705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease.
    Devi L; Alldred MJ; Ginsberg SD; Ohno M
    PLoS One; 2012; 7(3):e32792. PubMed ID: 22403710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease.
    Kizuka Y; Kitazume S; Fujinawa R; Saito T; Iwata N; Saido TC; Nakano M; Yamaguchi Y; Hashimoto Y; Staufenbiel M; Hatsuta H; Murayama S; Manya H; Endo T; Taniguchi N
    EMBO Mol Med; 2015 Feb; 7(2):175-89. PubMed ID: 25592972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels.
    Deng QS; Dong XY; Wu H; Wang W; Wang ZT; Zhu JW; Liu CF; Jia WQ; Zhang Y; Schachner M; Ma QH; Xu RX
    Neuropsychopharmacology; 2016 Jan; 41(2):440-53. PubMed ID: 26062786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SUMO1 modulates Aβ generation via BACE1 accumulation.
    Yun SM; Cho SJ; Song JC; Song SY; Jo SA; Jo C; Yoon K; Tanzi RE; Choi EJ; Koh YH
    Neurobiol Aging; 2013 Mar; 34(3):650-62. PubMed ID: 22975420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.